Clinical evidence - Non-metastatic prostate cancer

被引：0
|
作者：
Wilt, TJ
Brawer, MK
机构：
[1] NW Prostate Inst, Seattle, WA 98133 USA
[2] Minneapolis VA Hosp, Ctr Chron Dis Outcomes Res, Minneapolis, MN 55417 USA
来源：
WESTERN JOURNAL OF MEDICINE | 1999年 / 171卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
This article comes from Clinical Evidence, a new resource for clinicians, produced jointly by the BMJ Publishing Group and the American College of Physicians-American Society of Internal Medicine. Clinical Evidence is an extensively peer-reviewed publication that summarizes the best available evidence on the effects of common clinical interventions gleaned from thorough searches and appraisal of the world literature. The first issue is available in book form in the United Kingdom, with a United States version planned for publication in October. The second issue, updated and expanded to cover more topics and questions, will be published 6 months later. Please see the advertisement For more information or visit our web site at www.evidence.org.
引用
收藏
页码：97 / 101
页数：5
相关论文
共 50 条
  • [11] SEXUAL PERFORMANCE EVALUATION IN NON-METASTATIC PROSTATE CANCER PATIENTS
    Held, P. A.
    Matheus, W. E.
    Naccarato, A. M. E. P.
    Rodrigues, R. C. M.
    Ferruccio, A. A.
    Ferreira, U.
    JOURNAL OF SEXUAL MEDICINE, 2020, 17 (09): : S265 - S265
  • [12] Darolutamide for non-metastatic castration- resistant prostate cancer
    Kao, Jia-Horng
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2023, 122 (04) : 293 - 295
  • [13] Darolutamide for non-metastatic, castration-resistant prostate cancer
    Burki, Talha
    LANCET ONCOLOGY, 2019, 20 (03): : E139 - E139
  • [14] Systemic Therapies for Non-Metastatic Prostate Cancer: Review of the Literature
    Jereczek-Fossa, Barbara Alicja
    Curigliano, Giuseppe
    Orecchia, Roberto
    ONKOLOGIE, 2009, 32 (06): : 359 - 363
  • [15] The treatment patterns of non-metastatic prostate cancer in an Asian country
    Huang, E. Y. H.
    Yu, H. -J.
    Chang, Y. H.
    Wu, T. T.
    Cha, T. -L.
    Pang, S-T.
    Huang, S-P.
    Pan, C-C.
    Cheng, J. C-H.
    Hsieh, R-K.
    Peng, R-S.
    Ku, H-Y.
    Liu, T-W.
    INTERNATIONAL JOURNAL OF UROLOGY, 2017, 24 : 98 - 98
  • [16] Tissue immunostaining of candidate prognostic proteins in metastatic and non-metastatic prostate cancer
    Érica Romão Pereira
    Laís Capelasso Lucas Pinheiro
    Amanda Letícia Francelino
    Carlos Alberto Miqueloto
    Alda Fiorina Maria Losi Guembarovski
    Karen Brajão de Oliveira
    Paulo Emílio Fuganti
    Ilce Mara de Syllos Cólus
    Roberta Losi Guembarovski
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 567 - 577
  • [17] Tissue immunostaining of candidate prognostic proteins in metastatic and non-metastatic prostate cancer
    Pereira, Erica Romao
    Lucas Pinheiro, Lais Capelasso
    Francelino, Amanda Leticia
    Miqueloto, Carlos Alberto
    Maria Losi Guembarovski, Alda Fiorina
    de Oliveira, Karen Brajao
    Fuganti, Paulo Emilio
    de Syllos Colus, Ilce Mara
    Guembarovski, Roberta Losi
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (02) : 567 - 577
  • [18] Tumor and Plasma Met Levels in Non-Metastatic Prostate Cancer
    Kaye, Deborah R.
    Pinto, Peter A.
    Cecchi, Fabiola
    Reilly, Joseph
    Semerjian, Alice
    Rabe, Daniel C.
    Gupta, Gopal
    Choyke, Peter L.
    Bottaro, Donald P.
    PLOS ONE, 2016, 11 (06):
  • [19] Non-metastatic castrate-resistant prostate cancer: a call for improved guidance on clinical management
    Francois Rozet
    Thierry Roumeguère
    Martin Spahn
    Dirk Beyersdorff
    Peter Hammerer
    World Journal of Urology, 2016, 34 : 1505 - 1513
  • [20] Non-metastatic castrate-resistant prostate cancer: a call for improved guidance on clinical management
    Rozet, Francois
    Roumeguere, Thierry
    Spahn, Martin
    Beyersdorff, Dirk
    Hammerer, Peter
    WORLD JOURNAL OF UROLOGY, 2016, 34 (11) : 1505 - 1513
12345